Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

36.16
+0.10500.29%
Volume:1.24M
Turnover:45.05M
Market Cap:42.12B
PE:60.26
High:36.54
Open:36.46
Low:35.86
Close:36.05
52wk High:38.37
52wk Low:18.14
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.65
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.43
PE(LYR):29.88

Loading ...

Teva put volume heavy and directionally bearish

TIPRANKS
·
Jun 09

Teva presents positive long-term study data for Austedo

TIPRANKS
·
Jun 08

Teva’s Data on Austedo® (Deutetrabenazine) Tablets and Austedo Xr® (Deutetrabenazine) Extended-Release Tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care

THOMSON REUTERS
·
Jun 08

Alvotech Says FDA Agreed to Review Application for Biosimilar of Entyvio; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 08

Teva Says AUSTEDO Improves Quality of Life in Huntington's Disease Study

MT Newswires Live
·
Jun 06

Teva announces new data on AUSTEDO tablets, AUSTEDO XR tablets

TIPRANKS
·
Jun 05

Teva launches Ahzantive in Europe

TIPRANKS
·
Jun 04

Teva Pharmaceutical Industries Rolls Out Ahzantive in Europe to Treat Retinal Diseases

MT Newswires Live
·
Jun 04

BRIEF-Teva Expands European Biosimilars Portfolio With Launch Of AHZANTIVE Biosimilar To Eylea

Reuters
·
Jun 04

Teva - Expects to Launch Ahzantive in More Markets Later in 2026

THOMSON REUTERS
·
Jun 04

Teva Expands European Biosimilars Portfolio With Launch of Ahzantive® (Aflibercept) Biosimilar to Eylea®

THOMSON REUTERS
·
Jun 04

Alvotech, Teva Resubmit 2 Proposed Biosimilar Applications to the FDA for Retinal Treatment

MT Newswires Live
·
Jun 04

Update: UroGen Settles Patent Dispute With Teva; Generic Jelmyto Delayed Until 2030

MT Newswires Live
·
Jun 02

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Jun 01

Teva Shareholders Back Board, Executive Pay and Auditor

TIPRANKS
·
May 29

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Thermo Fisher (TMO) and Eli Lilly & Co (LLY)

TIPRANKS
·
May 27

Teva announces EMA acceptance of MAA for olanzapine long-acting injectable

TIPRANKS
·
May 22

Teva Study Finds Only 23% of Younger Adults With Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed With TD Despite Widespread Impact

THOMSON REUTERS
·
May 18

Teva put volume heavy and directionally bearish

TIPRANKS
·
May 15

Teva, Upstart, Bloom, Corning, Seagate Insider Shock

TIPRANKS
·
May 09